Coronavirus test update, Sales and manufacturing update and COVID-19 test approved in India and Argentina

Paris, France and Camberley, UK – 30 March 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to provide an update regarding the novel coronavirus (COVID-19) test developed by Primerdesign, the Company’s molecular diagnostics division based in the UK.